Which guideline recommends universal screening for gestational diabetes between 24-28 weeks of pregnancy?

The correct answer is ACOG (American College of Obstetricians and Gynecologists) because this organization has established guidelines that recommend universal screening for gestational diabetes mellitus (GDM) for all pregnant individuals between 24 to 28 weeks of gestation. This screening is crucial as GDM can lead to several complications for both the mother and the unborn child if not appropriately diagnosed and managed.

ACOG emphasizes the importance of this timing for screening because many women may not show symptoms, and the physiological changes of pregnancy can mask diabetes prior to this period. By screening during this window, healthcare providers can identify those who may require interventions, such as lifestyle changes or insulin therapy, leading to better maternal and fetal outcomes.

Other organizations, such as the ADA (American Diabetes Association), also recommend similar screening practices, but ACOG's guidelines specifically direct this universal approach within the gestational timeframe. The USPSTF (United States Preventive Services Task Force) and WHO (World Health Organization) provide recommendations on diabetes screening but do not universally advocate for screening specifically during the 24-28 week period as strongly as ACOG does, nor do they outline the specific parameters as clearly in the context of pregnancy.